TriHealth Cancer Institute is a clinical research site located in Cincinnati, Ohio, United States 45220.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
TriHealth Cancer Institute has participated in 8 clinical trials with 3 currently active.
Therapeutic areas: Relapsed and/or Refractory Multiple Myeloma (RRMM), Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer.
Sponsors: Takeda, Tempus AI, Calithera Biosciences, Inc.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
TriHealth Cancer Institute has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
TriHealth Cancer Institute has 8 clinical trials on record, with 3 currently active. Their work covers Relapsed and/or Refractory Multiple Myeloma (RRMM), Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer.
Yes — TriHealth Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.